{"id":408537,"date":"2021-01-05T08:33:34","date_gmt":"2021-01-05T13:33:34","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=408537"},"modified":"2021-01-05T08:33:34","modified_gmt":"2021-01-05T13:33:34","slug":"simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\/","title":{"rendered":"Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus\u00ae ACAT\u2122 Model for Oral Absorption of Peptides"},"content":{"rendered":"

<\/p>\n

Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus\u00ae ACAT\u2122 Model for Oral Absorption of Peptides<\/b><\/p>\n

New modeling approaches will accelerate the evaluation of innovative formulation strategies<\/i><\/b><\/p>\n

LANCASTER, Calif.–(BUSINESS WIRE<\/a>)–
\nSimulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has entered into a new funded collaboration with a large pharmaceutical company to add novel mechanisms for oral peptide formulations within the top-rated GastroPlus\u00ae Advanced Compartmental Absorption and Transit (ACAT\u2122) mechanistic model.\n<\/p>\n

\n\u201cOur partner, a frequent user of the GastroPlus<\/a> platform across multiple research sites worldwide, has a growing portion of their development pipeline focused on therapeutic peptides and proteins,\u201d said Dr. Viera Lukacova<\/a>, chief scientist at Simulations Plus. \u201cPart of their strategy involves designing oral delivery systems which can safely and efficiently complement the traditional invasive routes for these biomolecules. In this new collaborative effort, we will expand the applicability of GastroPlus to simulate intestinal absorption of larger molecules and the effect of permeation enhancers within oral formulations. The novel approaches and workflows will be validated through unique data provided to us by our partner, with the results serving as the foundational elements for peer-reviewed journal manuscripts describing the exciting improvements.\u201d\n<\/p>\n

\n\u201cWhat a great way to kick off 2021,\u201d added John DiBella<\/a>, Lancaster division president for Simulations Plus. \u201cOver the past several years, we have driven advances in modeling and simulation science for injectable formulations of both small and large molecules. With the market for oral delivery of therapeutic peptides and proteins expected to increase significantly over the next several years, it was important for us to partner with experts and embrace a leadership role to expand oral absorption modeling beyond small molecules. Like other funded collaborations, we will own all improvements made to our software programs, and our entire user community can access these new capabilities to accelerate research timelines and develop better medicines for the patients we all serve. We continue to welcome and invite future collaborations<\/a> across our entire suite of software programs.\u201d\n<\/p>\n

About Simulations Plus, Inc.<\/b><\/p>\n

\nSimulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With our subsidiaries, Cognigen<\/a>, DILIsym Services<\/a>, and Lixoft<\/a>, we offer solutions which bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology\/toxicology, and population PK\/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com<\/a>.\n<\/p>\n

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995<\/b> \u2013 With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. Words like \u201cbelieve,\u201d \u201cexpect\u201d and \u201canticipate\u201d mean that these are our best estimates as of this writing, but that there can be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to: our ability to maintain our competitive advantages, acceptance of new software and improved versions of our existing software by our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to attract and retain highly qualified technical staff, our ability to identify and close acquisitions on terms favorable to the Company, and a sustainable market. Further information on our risk factors is contained in our quarterly and annual reports and filed with the U.S. Securities and Exchange Commission.\n<\/p>\n

\nFollow us on Twitter<\/a> | LinkedIn<\/a><\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210105005260\/en\/<\/a><\/span><\/p>\n

Simulations Plus Investor Relations
\n<\/span>
Ms. Renee Bouche
\n
661-723-7723
\n
renee@simulations-plus.com
\n<\/a><\/p>\n

Hayden IR
\n<\/span>
Mr. Cameron Donahue
\n
651-653-1854
\n
slp@haydenir.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America California<\/p>\n

INDUSTRY KEYWORDS:<\/b> Health Technology Software Research Science Pharmaceutical Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus\u00ae ACAT\u2122 Model for Oral Absorption of Peptides New modeling approaches will accelerate the evaluation of innovative formulation strategies LANCASTER, Calif.–(BUSINESS WIRE)– Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has entered into a new funded collaboration with a large pharmaceutical company to add novel mechanisms for oral peptide formulations within the top-rated GastroPlus\u00ae Advanced Compartmental Absorption and Transit (ACAT\u2122) mechanistic model. \u201cOur partner, a frequent user of the GastroPlus platform across multiple research sites worldwide, has a growing portion of their development pipeline focused on therapeutic peptides and proteins,\u201d said Dr. Viera … <\/p>\n

Continue reading “Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus\u00ae ACAT\u2122 Model for Oral Absorption of Peptides”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-408537","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSimulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus\u00ae ACAT\u2122 Model for Oral Absorption of Peptides - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus\u00ae ACAT\u2122 Model for Oral Absorption of Peptides - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus\u00ae ACAT\u2122 Model for Oral Absorption of Peptides New modeling approaches will accelerate the evaluation of innovative formulation strategies LANCASTER, Calif.–(BUSINESS WIRE)– Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has entered into a new funded collaboration with a large pharmaceutical company to add novel mechanisms for oral peptide formulations within the top-rated GastroPlus\u00ae Advanced Compartmental Absorption and Transit (ACAT\u2122) mechanistic model. \u201cOur partner, a frequent user of the GastroPlus platform across multiple research sites worldwide, has a growing portion of their development pipeline focused on therapeutic peptides and proteins,\u201d said Dr. Viera … Continue reading "Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus\u00ae ACAT\u2122 Model for Oral Absorption of Peptides"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-05T13:33:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210105005260r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus\u00ae ACAT\u2122 Model for Oral Absorption of Peptides\",\"datePublished\":\"2021-01-05T13:33:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\\\/\"},\"wordCount\":685,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210105005260r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\\\/\",\"name\":\"Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus\u00ae ACAT\u2122 Model for Oral Absorption of Peptides - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210105005260r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-01-05T13:33:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210105005260r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210105005260r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus\u00ae ACAT\u2122 Model for Oral Absorption of Peptides\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus\u00ae ACAT\u2122 Model for Oral Absorption of Peptides - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\/","og_locale":"en_US","og_type":"article","og_title":"Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus\u00ae ACAT\u2122 Model for Oral Absorption of Peptides - Market Newsdesk","og_description":"Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus\u00ae ACAT\u2122 Model for Oral Absorption of Peptides New modeling approaches will accelerate the evaluation of innovative formulation strategies LANCASTER, Calif.–(BUSINESS WIRE)– Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has entered into a new funded collaboration with a large pharmaceutical company to add novel mechanisms for oral peptide formulations within the top-rated GastroPlus\u00ae Advanced Compartmental Absorption and Transit (ACAT\u2122) mechanistic model. \u201cOur partner, a frequent user of the GastroPlus platform across multiple research sites worldwide, has a growing portion of their development pipeline focused on therapeutic peptides and proteins,\u201d said Dr. Viera … Continue reading \"Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus\u00ae ACAT\u2122 Model for Oral Absorption of Peptides\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-05T13:33:34+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210105005260r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus\u00ae ACAT\u2122 Model for Oral Absorption of Peptides","datePublished":"2021-01-05T13:33:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\/"},"wordCount":685,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210105005260r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\/","name":"Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus\u00ae ACAT\u2122 Model for Oral Absorption of Peptides - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210105005260r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-01-05T13:33:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210105005260r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210105005260r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-enters-new-funded-collaboration-to-enhance-top-rated-gastroplus-acat-model-for-oral-absorption-of-peptides\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus\u00ae ACAT\u2122 Model for Oral Absorption of Peptides"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=408537"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408537\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=408537"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=408537"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=408537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}